Literature DB >> 28861889

Red yeast rice prevents atherosclerosis through regulating inflammatory signaling pathways.

Min Wu1, Wen-Gao Zhang2, Long-Tao Liu3.   

Abstract

OBJECTIVE: To observe the effects of red yeast rice (RYR) on blood lipid levels, aortic atherosclerosis (AS), and plaque stability in apolipoprotein E gene knockout (ApoE-/-) mice.
METHODS: Twenty-four ApoE-/- mice were fed with a high-fat diet starting from 6 weeks of age. Mice were randomized into three groups (n = 8 in each group): model group (ApoE-/- group), RYR group (ApoE-/- + RYR group), and simvastatin group (ApoE-/- + simvastatin group). Eight 6-week-old C57BL/6 mice were assigned as the control group and fed with a basic diet. After 36 weeks, plasma lipids and inflflammatory factors were measured. Aortic atherosclerotic lesions by microscope, scanning electron microscope and transmission electron microscope were observed. Plasma levels of interleukin-6 (IL-6) and tumor necrosis factor-α (TNF-α) were measured with enzyme-linked immunosorbent assay. The level of high sensitivity C-reaction protein (Hs-CRP) was detected by the scattering immunoturbidimetric assay. Protein expression of matrix metalloproteinase-9 (MMP-9) and nuclear factor κB (NF-κB) in aorta were tested by immunohistochemistry.
RESULTS: Compared with the model group, treatment with RYR significantly decreased the levels of total cholesterol, triglyceride, low-density lipoprotein cholesterol, lipoprotein (a), and apolipoprotein B100 in ApoE-/- mice (P<0.01). Compared with the model group, treatment with RYR decreased the levels of Hs-CRP, IL-6, and TNF-α (P<0.01). RYR also reduced the protein levels of NF-κB and MMP-9 of the aorta.
CONCLUSIONS: RYR has the anti-atherosclerotic and stabilizing unstable plaque effects. The mechanism might be related to the inflflammatory signaling pathways.

Entities:  

Keywords:  atherosclerosis; inflflammatory signaling pathway; red yeast rice; stabilizing unstable plaque

Mesh:

Substances:

Year:  2017        PMID: 28861889     DOI: 10.1007/s11655-017-2416-x

Source DB:  PubMed          Journal:  Chin J Integr Med        ISSN: 1672-0415            Impact factor:   1.978


  26 in total

1.  AHA/ACCF Secondary Prevention and Risk Reduction Therapy for Patients with Coronary and other Atherosclerotic Vascular Disease: 2011 update: a guideline from the American Heart Association and American College of Cardiology Foundation.

Authors:  Sidney C Smith; Emelia J Benjamin; Robert O Bonow; Lynne T Braun; Mark A Creager; Barry A Franklin; Raymond J Gibbons; Scott M Grundy; Loren F Hiratzka; Daniel W Jones; Donald M Lloyd-Jones; Margo Minissian; Lori Mosca; Eric D Peterson; Ralph L Sacco; John Spertus; James H Stein; Kathryn A Taubert
Journal:  Circulation       Date:  2011-11-03       Impact factor: 29.690

Review 2.  Review of red yeast rice content and current Food and Drug Administration oversight.

Authors:  Lindsey Childress; Andrea Gay; Atanaz Zargar; Matthew K Ito
Journal:  J Clin Lipidol       Date:  2012-09-25       Impact factor: 4.766

3.  Lipid-lowering efficacy of red yeast rice in a population intolerant to statins.

Authors:  Carmelo V Venero; Jose V Venero; Dale C Wortham; Paul D Thompson
Journal:  Am J Cardiol       Date:  2010-03-01       Impact factor: 2.778

4.  Quantitative assessment of atherosclerotic lesions in mice.

Authors:  B Paigen; A Morrow; P A Holmes; D Mitchell; R A Williams
Journal:  Atherosclerosis       Date:  1987-12       Impact factor: 5.162

5.  Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques.

Authors:  Z S Galis; G K Sukhova; M W Lark; P Libby
Journal:  J Clin Invest       Date:  1994-12       Impact factor: 14.808

Review 6.  The effect of red yeast rice (Monascus purpureus) in dyslipidemia and other disorders.

Authors:  Clinton W Yang; Shaker A Mousa
Journal:  Complement Ther Med       Date:  2012-08-17       Impact factor: 2.446

7.  IKKε knockout prevents high fat diet induced arterial atherosclerosis and NF-κB signaling in mice.

Authors:  Changchun Cao; Yifan Zhu; Wen Chen; Liangpeng Li; Yongchao Qi; Xiaodi Wang; Ye Zhao; Xin Wan; Xin Chen
Journal:  PLoS One       Date:  2013-05-31       Impact factor: 3.240

8.  Ginkgolide B reduces atherogenesis and vascular inflammation in ApoE(-/-) mice.

Authors:  Xiyun Liu; Gexin Zhao; Yan Yan; Li Bao; Beidong Chen; Ruomei Qi
Journal:  PLoS One       Date:  2012-05-11       Impact factor: 3.240

9.  Plaque rupture is a determinant of vascular events in carotid artery atherosclerotic disease: involvement of matrix metalloproteinases 2 and 9.

Authors:  Sung Hyuk Heo; Chang-Hoon Cho; Hye Ok Kim; Yong Hwa Jo; Kyung-Sik Yoon; Ju Hie Lee; Ju-Cheol Park; Key Chung Park; Tae-Beom Ahn; Kyung Cheon Chung; Sung-Sang Yoon; Dae-Il Chang
Journal:  J Clin Neurol       Date:  2011-06-28       Impact factor: 3.077

10.  Oxidative stress induced age dependent meibomian gland dysfunction in Cu, Zn-superoxide dismutase-1 (Sod1) knockout mice.

Authors:  Osama M A Ibrahim; Murat Dogru; Yukihiro Matsumoto; Ayako Igarashi; Takashi Kojima; Tais Hitomi Wakamatsu; Takaaki Inaba; Takahiko Shimizu; Jun Shimazaki; Kazuo Tsubota
Journal:  PLoS One       Date:  2014-07-18       Impact factor: 3.240

View more
  3 in total

Review 1.  Cholesterol-Lowering Nutraceuticals Affecting Vascular Function and Cardiovascular Disease Risk.

Authors:  Vanessa Bianconi; Massimo Raffaele Mannarino; Amirhossein Sahebkar; Teresa Cosentino; Matteo Pirro
Journal:  Curr Cardiol Rep       Date:  2018-05-25       Impact factor: 2.931

Review 2.  Research Progress of Angiogenesis in Atherosclerotic Plaque in Chinese Medicine and Western Medicine.

Authors:  Lan Ma; Jin Dai; Jie Chen; Hong-Wen Cai; Jia-Ying Li; Xin-Yao Li; Shen-Jie Chen; Wei Mao
Journal:  Chin J Integr Med       Date:  2018-09-04       Impact factor: 1.978

3.  Red Yeast Rice: A Systematic Review of the Traditional Uses, Chemistry, Pharmacology, and Quality Control of an Important Chinese Folk Medicine.

Authors:  Bo Zhu; Fangyuan Qi; Jianjun Wu; Guoqing Yin; Jinwei Hua; Qiaoyan Zhang; Luping Qin
Journal:  Front Pharmacol       Date:  2019-12-02       Impact factor: 5.810

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.